Literature DB >> 7161115

Steroid treatment of pseudo-croup.

K E von Mühlendahl, D Kahn, H L Spohr, F Dressler.   

Abstract

In a randomized, controlled investigation, 349 children with pseudo-croup stage I or II were given 6 mg of dexamethasone or placebo. Although the rate of recovery was similar in both groups, there was a significant difference when only the more seriously affected children were considered: steroid treated patients recovered quicker. Steroids appear to be useful in the routine treatment of simple, uncomplicated pseudo-croup, even if their effect apparently is not very impressive. Thus, close supervision remains the most important measure in this nearly always benign but potentially dangerous condition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7161115

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  7 in total

1.  Steroid therapy for croup in children admitted to hospital. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

Review 2.  Management of childhood croup.

Authors:  W B Macdonald; G C Geelhoed
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

Review 3.  A risk-benefit assessment of corticosteroids in the management of croup.

Authors:  R W Yates; I J Doull
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

Review 4.  Management of croup.

Authors:  Wendy Stannard; Chris O'Callaghan
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial.

Authors:  G C Geelhoed; J Turner; W B Macdonald
Journal:  BMJ       Date:  1996-07-20

6.  Glucocorticoids for croup in children.

Authors:  Allison Gates; Michelle Gates; Ben Vandermeer; Cydney Johnson; Lisa Hartling; David W Johnson; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2018-08-22

Review 7.  Infraglottic and bronchial infections.

Authors:  A Uba
Journal:  Prim Care       Date:  1996-12       Impact factor: 2.907

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.